KILITCH DRUGS (INDIA) Financial Statement Analysis
|
||
|
The Revenues of KILITCH DRUGS (INDIA) have increased by 18.74% YoY .
The Earnings Per Share (EPS) of KILITCH DRUGS (INDIA) has decreased by -52.14 % YoY. |
||
KILITCH DRUGS (INDIA) Last 5 Annual Financial Results
[BOM: 524500|NSE : KILITCH]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹235 Cr | ₹198 Cr | ₹154 Cr | ₹140 Cr | ₹114 Cr |
| Expenses | ₹198 Cr | ₹167 Cr | ₹130 Cr | ₹122 Cr | ₹104 Cr |
| Operating Profit (Excl OI) | ₹37 Cr | ₹32 Cr | ₹24 Cr | ₹18 Cr | ₹11 Cr |
| Other Income | ₹11 Cr | ₹11 Cr | ₹4.48 Cr | ₹2.92 Cr | ₹2.91 Cr |
| Interest | ₹6.29 Cr | ₹5.32 Cr | ₹6.04 Cr | ₹5.08 Cr | ₹1.33 Cr |
| Depreciation | ₹3.62 Cr | ₹3.11 Cr | ₹3.35 Cr | ₹3.55 Cr | ₹2.47 Cr |
| Profit Before Tax | ₹39 Cr | ₹34 Cr | ₹19 Cr | ₹12 Cr | ₹9.61 Cr |
| Profit After Tax | ₹30 Cr | ₹25 Cr | ₹14 Cr | ₹8.28 Cr | ₹6.21 Cr |
| Consolidated Net Profit | ₹30 Cr | ₹27 Cr | ₹15 Cr | ₹10 Cr | ₹7.37 Cr |
| Earnings Per Share (Rs) | ₹9.27 | ₹19.37 | ₹9.08 | ₹6.71 | ₹4.73 |
| PAT Margin (%) | 17.18 | 17.16 | 8.79 | 5.93 | 5.44 |
| ROE(%) | 11.07 | 14.54 | 8.43 | 5.86 | 4.73 |
| ROCE(%) | 12.37 | 16.90 | 13.30 | 10.26 | 7.26 |
| Total Debt/Equity(x) | 0.27 | 0.19 | 0.18 | 0.15 | 0.15 |
Key Financials |
||
| Market Cap | : | ₹ 657.7 Cr |
| Revenue (TTM) | : | ₹ 235.5 Cr |
| Net Profit(TTM) | : | ₹ 29.5 Cr |
| EPS (TTM) | : | ₹ 8.4 |
| P/E (TTM) | : | 22.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KILITCH DRUGS (INDIA) | -2.9% | 3.6% | -11.4% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.3% | -0.5% | 21.4% |
| DIVIS LABORATORIES | 3.1% | 16.7% | 39.3% |
| TORRENT PHARMACEUTICALS | -1.5% | -2.8% | 38.7% |
| CIPLA | -0.8% | 1.6% | -1.7% |
| DR REDDYS LABORATORIES | 2.9% | -1.9% | 0.2% |
| MANKIND PHARMA | -0.9% | -5.1% | -5% |
| LUPIN | -4.2% | -9.3% | 22.3% |
| ZYDUS LIFESCIENCES | 5.2% | 1.6% | 29.1% |
KILITCH DRUGS (INDIA) Revenues
[BOM: 524500|NSE : KILITCH]
| Y-o-Y | 18.74 % |
| 5 Yr CAGR | 19.82 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹235 Cr | 18.74 | |
| Mar2025 | ₹198 Cr | 28.47 | |
| Mar2024 | ₹154 Cr | 10.58 | |
| Mar2023 | ₹140 Cr | 22.20 | |
| Mar2022 | ₹114 Cr | - | |
KILITCH DRUGS (INDIA) Operating Profit
[BOM: 524500|NSE : KILITCH]
| Y-o-Y | 17.59 % |
| 5 Yr CAGR | 37.31 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹37 Cr | 17.59 | |
| Mar2025 | ₹32 Cr | 30.84 | |
| Mar2024 | ₹24 Cr | 36.84 | |
| Mar2023 | ₹18 Cr | 68.82 | |
| Mar2022 | ₹11 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -1.00 % |
| 5 Yr CAGR | 14.60 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 15.85% | -1.00 | |
| Mar2025 | 16.01% | 1.84 | |
| Mar2024 | 15.72% | 23.78 | |
| Mar2023 | 12.7% | 38.19 | |
| Mar2022 | 9.19% | - | |
KILITCH DRUGS (INDIA) Profit After Tax
[BOM: 524500|NSE : KILITCH]
| Y-o-Y | 12.98 % |
| 5 Yr CAGR | 42.25 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹30 Cr | 12.98 | |
| Mar2025 | ₹27 Cr | 82.87 | |
| Mar2024 | ₹15 Cr | 39.75 | |
| Mar2023 | ₹10 Cr | 41.82 | |
| Mar2022 | ₹7.37 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 0.12 % |
| 5 Yr CAGR | 33.31 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 17.18 % | 0.12 | |
| Mar2025 | 17.16 % | 95.22 | |
| Mar2024 | 8.79 % | 48.23 | |
| Mar2023 | 5.93 % | 9.01 | |
| Mar2022 | 5.44 % | - | |
KILITCH DRUGS (INDIA) Earnings Per Share (EPS)
[BOM: 524500|NSE : KILITCH]
| Y-o-Y | -52.14 % |
| 5 Yr CAGR | 18.32 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹9.27 | -52.14 | |
| Mar2025 | ₹19 | 113.33 | |
| Mar2024 | ₹9.08 | 35.32 | |
| Mar2023 | ₹6.71 | 41.86 | |
| Mar2022 | ₹4.73 | - | |
KILITCH DRUGS (INDIA) Return on Capital Employed (ROCE)
[BOM: 524500|NSE : KILITCH]
| Y-o-Y | -26.80 % |
| 5 Yr CAGR | 14.25 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 12.37% | -26.80 | |
| Mar2025 | 16.9% | 27.07 | |
| Mar2024 | 13.3% | 29.63 | |
| Mar2023 | 10.26% | 41.32 | |
| Mar2022 | 7.26% | - | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Current Share Price | : | ₹187.9 |
| Current MarketCap | : | ₹ 657.7 Cr |
| Updated EOD on | : | Aug 13,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -2.9% |
3.6% |
-11.4% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
KILITCH DRUGS (INDIA) related INDICES
You may also like the below Video Courses
FAQ about KILITCH DRUGS (INDIA) Financials
How the annual revenues of KILITCH DRUGS (INDIA) have changed ?
The Revenues of KILITCH DRUGS (INDIA) have increased by 18.74% YoY .
How the Earnings per Share (EPS) of KILITCH DRUGS (INDIA) have changed?
The Earnings Per Share (EPS) of KILITCH DRUGS (INDIA) has decreased by -52.14 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs